Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
09 May 2024 - 3:44AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the
month of May 2024
Commission
File Number 001-15170
GSK plc
(Translation
of registrant's name into English)
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F . . . .X. . . . Form 40-F . . . . . . . .
GSK
plc
Results of 24th Annual
General Meeting
GSK plc ('GSK') held a hybrid Annual General Meeting ('AGM') at
2.30pm on Wednesday 8 May 2024 at the Royal Lancaster London,
Lancaster Terrace, London, W2 2TY. Shareholders were able to join
the meeting in person or virtually via the Lumi AGM
website.
All valid proxy votes (whether submitted electronically or in hard
copy form) were included in the poll taken at the
meeting.
The table below shows the results of the poll on all 23
resolutions. The full text of the resolutions is contained in the
Notice of AGM published on 25 March 2024, which is available on
GSK's website at www.gsk.com.
Resolution
|
Total votes for(1)(2)
|
%
|
Total votes against(2)
|
%
|
Total votes cast
|
Votes withheld(3)
|
1
|
Receive and adopt the 2023 Annual Report
|
3,026,657,634
|
99.93
|
1,985,899
|
0.07
|
3,028,643,533
|
11,560,313
|
2
|
Approve the Annual report on remuneration
|
2,782,337,600
|
92.70
|
219,140,461
|
7.30
|
3,001,478,061
|
38,693,019
|
3
|
Election of Wendy Becker
|
2,908,153,080
|
95.87
|
125,392,399
|
4.13
|
3,033,545,479
|
6,609,293
|
4
|
Election od Dr Jeannie Lee
|
3,029,569,885
|
99.87
|
4,058,143
|
0.13
|
3,033,628,028
|
6,567,803
|
5
|
Re-election of Sir Jonathan Symonds
|
3,018,694,064
|
99.51
|
14,982,162
|
0.49
|
3,033,676,226
|
6,516,614
|
6
|
Re-election of Dame Emma Walmsley
|
3,028,232,685
|
99.81
|
5,822,706
|
0.19
|
3,034,055,391
|
6,142,099
|
7
|
Re-election of Julie Brown
|
3,024,167,039
|
99.68
|
9,628,961
|
0.32
|
3,033,796,000
|
6,386,918
|
8
|
Re-election of Elizabeth McKee Anderson
|
2,960,185,482
|
97.57
|
73,605,787
|
2.43
|
3,033,791,269
|
6,404,117
|
9
|
Re-election of Charles Bancroft
|
3,019,529,985
|
99.54
|
13,986,857
|
0.46
|
3,033,516,842
|
6,668,927
|
10
|
Re-election of Dr Hal Barron
|
3,022,032,114
|
99.61
|
11,790,927
|
0.39
|
3,033,823,041
|
6,360,307
|
11
|
Re-election of Dr Anne Beal
|
3,021,808,961
|
99.60
|
12,038,342
|
0.40
|
3,033,847,303
|
6,336,638
|
12
|
Re-election of Dr Harry C Dietz
|
3,029,031,724
|
99.85
|
4,650,326
|
0.15
|
3,033,682,050
|
6,508,974
|
13
|
Re-election of Dr Jesse Goodman
|
3,028,663,561
|
99.84
|
4,930,361
|
0.16
|
3,033,593,922
|
6,598,956
|
14
|
Re-election of Dr Vishal Sikka
|
2,868,354,507
|
94.57
|
164,801,089
|
5.43
|
3,033,155,596
|
7,017,053
|
15
|
Re-appointment of the auditor
|
3,014,623,759
|
99.95
|
1,608,077
|
0.05
|
3,016,231,836
|
23,950,717
|
16
|
Remuneration of the auditor
|
3,031,902,105
|
99.92
|
2,552,472
|
0.08
|
3,034,454,577
|
5,710,703
|
17
|
Authority for the company to make donations to political
organisations and incur political expenditure
|
2,932,886,023
|
98.76
|
36,920,830
|
1.24
|
2,969,806,853
|
70,418,813
|
18
|
Authority to allot shares
|
2,902,088,897
|
95.68
|
130,945,918
|
4.32
|
3,033,034,815
|
7,163,455
|
19
|
Disapplication of pre-emption rights - general
power(4)
|
2,961,493,840
|
97.71
|
69,555,193
|
2.29
|
3,031,049,033
|
9,105,429
|
20
|
Disapplication of pre-emption rights - in connection with an
acquisition or specified capital investment(4)
|
2,937,510,909
|
96.91
|
93,802,022
|
3.09
|
3,031,312,931
|
8,843,231
|
21
|
Authority for the company to purchase its own
shares(4)
|
3,007,905,874
|
99.25
|
22,735,155
|
0.75
|
3,030,641,029
|
9,526,430
|
22
|
Exemption from statement of senior statutory auditor's
name
|
2,960,435,195
|
99.72
|
8,381,561
|
0.28
|
2,968,816,756
|
71,372,939
|
23
|
Authority for reduced notice of a general meeting other than an
AGM(4)
|
2,795,236,350
|
93.79
|
185,233,215
|
6.21
|
2,980,469,565
|
59,729,307
|
Notes:
(1)
The
"for" votes include those giving the Chair discretion.
(2)
Votes
"for" and "against" are expressed as a percentage of the total
votes cast.
(3)
A
"vote withheld" is not a vote in law and is not counted in the
calculation of the proportion of votes "for" or "against" a
resolution.
(4)
Indicates
Special Resolutions requiring a 75% majority of votes
cast.
The Company's issued share capital as at 3 May 2024 consisted of
4,144,937,355 shares of 31 ¼ pence each ('Ordinary Shares')
excluding Ordinary Shares held in
Treasury. Every
shareholder has one vote for every Ordinary Share
held.
The above poll results will shortly be available on the company's
website at www.gsk.com.
In accordance with Listing Rule 9.6.2 of the Financial Conduct
Authority's (FCA) Listing Rules, a copy of the resolutions, other
than those concerning ordinary business, will be submitted to the
FCA and will in due course be available for inspection
at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
V A Whyte
Company Secretary
8 May 2024
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorised.
|
GSK plc
|
|
(Registrant)
|
|
|
Date: May
8, 2024
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GSK plc
|
GSK (PK) (USOTC:GLAXF)
Historical Stock Chart
From Jul 2024 to Jul 2024
GSK (PK) (USOTC:GLAXF)
Historical Stock Chart
From Jul 2023 to Jul 2024